tenofovir disoproxil fumarate · Gilead Sciences Inc · NDA 021356, 022577
Viread
Earliest generic entry, as listed · earliest of 5 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Generic approved · ANDA 206157, Micro Labs · 021356-001Approved 18 Dec 2025Detected 25 Oct 2026Historical import
Products covered · 5
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 021356 · 001 · RLD | tablet, oral | 300MG | open |
| 021356 · 002 · RLD | tablet, oral | 150MG | open |
| 021356 · 003 · RLD | tablet, oral | 200MG | open |
| 021356 · 004 · RLD | tablet, oral | 250MG | open |
| 022577 · 001 · RLD | powder, oral | 40MG/SCOOPFUL | open |